LTR

Inhibitory Selectivity

LTR Products

Catalog No. Information Product Use Citations Product Validations
S3998

(+)-α-Lipoic acid

R(+)-α-lipoic acid, a physiological form of thioctic acid, is a strong antioxidant that relieves diabetic neuropathic symptoms. It shows superior antioxidative effects to its racemate. α-Lipoic Acid is an antioxidant, which is an essential cofactor of mitochondrial enzyme complexes. α-Lipoic Acid inhibits NF-κB-dependent HIV-1 LTR activation.

S1633

Zafirlukast

Zafirlukast is an oral leukotriene receptor antagonist (LTRA), used to prevent asthma symptoms.

S4211

Montelukast Sodium

Montelukast selectively antagonizes leukotriene D4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1. Montelukast improves macroautophagy but not the chaperone-mediated autophagy pathway. Precipitations may form after reconstitution,solution is best fresh-prepared.

S8126

MK571

MK-571 is a selective, orally active CysLT1 receptor(Cysteinyl leukotriene receptor) antagonist.

S5783

Montelukast

Montelukast is a leukotriene receptor antagonist used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.

Catalog No. Information Product Use Citations Product Validations
S3998

(+)-α-Lipoic acid

R(+)-α-lipoic acid, a physiological form of thioctic acid, is a strong antioxidant that relieves diabetic neuropathic symptoms. It shows superior antioxidative effects to its racemate. α-Lipoic Acid is an antioxidant, which is an essential cofactor of mitochondrial enzyme complexes. α-Lipoic Acid inhibits NF-κB-dependent HIV-1 LTR activation.

Catalog No. Information Product Use Citations Product Validations
S1633

Zafirlukast

Zafirlukast is an oral leukotriene receptor antagonist (LTRA), used to prevent asthma symptoms.

S4211

Montelukast Sodium

Montelukast selectively antagonizes leukotriene D4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1. Montelukast improves macroautophagy but not the chaperone-mediated autophagy pathway. Precipitations may form after reconstitution,solution is best fresh-prepared.

S8126

MK571

MK-571 is a selective, orally active CysLT1 receptor(Cysteinyl leukotriene receptor) antagonist.

S5783

Montelukast

Montelukast is a leukotriene receptor antagonist used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.